Susan little, dvm, diplomate abvp (feline)
Susan Little, DVM Diplomate, American Board of Veterinary Practitioners, Certified in Feline Practice
Infertility in the Queen
June 2006
Record Keeping Health and breeding records are very important; breeders of pedigreed cats need a
simple but complete system to record data for each breeding cat
Individual record for each cat:
a. Call name and registered name; registration number; microchip number b. Complete description and photo c. Birth date d. Sire and dam e. Vaccination and deworming record f. Record of major health problems and their treatment g. Record of elective procedures (i.e. dental cleanings, spay, neuter, etc.)
Additional records for breeding cats should include at a minimum:
a. Age at first heat b. Record of each heat and the breeding plans c. Record of any health problems during the pregnancy and of any
medications administered
d. Record of each breeding (name of tom, dates bred, number of breedings,
whether breeding was witnessed, any problems) and its outcome (i.e. pregnancy or date of return to heat)
e. Record of each pregnancy (projected due date, actual due date, number of
kittens born live/dead, any congenital defects or other problems)
f. Description of each delivery (length of time, interventions needed, etc.) g. Dates/results of any x-rays/ultrasounds done for reproductive reasons h. Birth weights of kittens, health problems in the neonatal period i. Health status of each kitten at 1 and 5 years of age, if known
Infertility Infertility may mean one of the following in female cats:
y Inability to be bred by a male y Inability to conceive after successful breeding y Inability to carry a pregnancy to term
Cats that are difficult to breed may produce other cats who are difficult to
Investigation of infertility in the queen requires:
1. A complete physical exam and thorough medical history (including drugs
or herbal products administered and vaccination history)
2. Blood chemistries, complete blood count, urinalysis, retrovirus testing 3. Vaginal cytology, serum progesterone to establish phase of estrous cycle 4. Evaluation of diet, housing, show/travel stresses
Bytown Cat Hospital 422 McArthur Ave. Ottawa, Ontario, Canada K1K 1G6
Phone 613-741-2460 [email protected] Fax 613-741-8463
5. Evaluation of social interactions with other cats in cattery 6. Evaluation of breeding behaviour when with male 7. Evaluation of cattery environment: temperature, ventilation, available
light, population density, cage design, etc. Resources for healthy indoor feline environments: Although this website is geared toward cats in research settings, there is valuable information for catteries:
Failure to Cycle Immaturity: First estrus may occur any time between 4 and 21 months of age Senility: Queens over 8 years old may have absent or infrequent estrus cycles Previous ovariohysterectomy/ovariectomy: Serum luteinizing hormone (LH) will be
over 1 ng/ml in OHE/ovariectomized females due to loss of negative feedback from ovaries
True primary anestrus: Queens that fail show first estrus by 24 months of age
(uncommon); evaluate karyotype for chromosomal abnormalities
Secondary anestrus: failure to cycle, or infrequent cycles
1. Silent estrus: Normal hormonal events without behavioral estrus
• Queens that are timid, low on social scale in cattery; crowded conditions
• Must differentiate from pseudopregnancy due to spontaneous ovulation
• House queen with different cats (smaller group) or separately; expose to tom
2. Inadequate daylight: Indoor housing may not ensure enough hours daylight
• 14-16 hours artificial light necessary; equivalent to 100-watt light bulb per
13 x 13 foot space; if you can read a newspaper, it is enough light
3. Spontaneous ovulation/pseudopregnancy: Noncopulatory ovulation may be a
cause of long interestrus intervals (40-50 days)
• Detect with vaginal cytology and elevated serum progesterone in the
absence of confirmed pregnancy
4. Intercurrent diseases/stressors: Conditions causing debilitation or prolonged ill
health may affect estrous cycles; stressors such as frequent exhibition/travel, crowding, antagonistic interactions with other cats may also suppress cycles
5. Medications: Some medications may interfere with estrous cycles by suppressing
gonadotropin secretion, such as corticosteroids, progestins, anabolic steroids, androgens; some antifungals such as ketoconazole can lower testosterone levels, griseofulvin could inhibit spermatogenesis
Galastop , Boehringer Ingelheim) may be useful in inducing estrus, not
well studied in the queen
FSH can be used to induce estrus in the queen, but prolonged usage has been
associated with cystic ovaries: • Day 1: 2.0 mg, IM; Days 2 and 3: 1.0 mg, IM; Days 4 and 5: 0.5 mg, IM
Bytown Cat Hospital 422 McArthur Ave. Ottawa, Ontario, Canada K1K 1G6
Phone 613-741-2460 [email protected] Fax 613-741-8463
Prolonged or Persistent Estrus
1. Normal phenomena:
• May be due to very short interestrus intervals or receptivity to mating during the
nonfollicular phase of the estrous cycle
• Investigate using vaginal cytology, serum estradiol levels every 2-3 days over a 3-
• Breed queen to an experienced male, or induce ovulation with GnRH (25 µg
intramuscularly)
• Try to induce anestrus by maintaining queen in less than 8-10 hours of daylight
2. Ovarian cysts and tumours:
• Cats can have both functional and non-functional ovarian and parovarian cysts;
tumours most common in older queens
• Evaluate with ultrasonography, serum estradiol levels
Failure to Conceive with a Normal Cycle
1. Maternal abnormalities:
• Congenital defects: persistent hymen, vaginal strictures
• Inbreeding depression: intensive inbreeding can cause subfertility, loss of vigor
and reproductive capacity
• Uterine disease: cystic endometrial hyperplasia (CEH)/pyometra
a. Ultrasound uterus (uterine wall thickness, fluid accumulation) b. Laparoscopy or laparotomy to visualize reproductive tract, biopsy/culture
uterus (for valuable queens)
c. Queens with repeated pseudopregnancies may have CEH d. Ultrasound 18-21 days after breeding to differentiate failure to conceive
from early fetal death
2. Male infertility: breed queen to a proven sire (sired kittens within previous 6
months); check male for presence of hair ring around base of penis that can prevent intromission
3. Breeding management issues:
• Review breeding management, videotape breedings if necessary
• Fearful queen may not breed, fear impairs hormonal events; dominant queens may
require sedation to allow male to breed (best medication to use not known)
• Partner preferences and aversions are known to occur • If queen returns to estrus less than 21 days after breeding, she did not ovulate,
probably due to inadequate breedings (incomplete breedings, too few breedings)
• Check timing of breeding (too early, too late); best to breed days 2-4
• Check serum progesterone 1-2 weeks after breeding to see if ovulation occurred;
ovulation is associated with serum progesterone > 2 ng/ml
4. Failure to ovulate: If breeding management issues have been ruled out as a cause,
ovulation can be induced with GnRH or hCG • Repeated treatments have been associated with immune-mediated decreases in
Bytown Cat Hospital 422 McArthur Ave. Ottawa, Ontario, Canada K1K 1G6
Phone 613-741-2460 [email protected] Fax 613-741-8463
5. Fetal resorption/abortion: Queen returns to estrus 60+ days after breeding
Cystic Endometrial Hyperplasia (CEH)
Disorder of proliferative and degenerative changes in endometrium associated with
aging; chronic subclinical condition; common in queens over 5 years and maiden queens over 3 years, but can be seen at any age
Progesterone induces hyperplasia of the surface or glandular epithelium and cystic
dilatation of the uterine glands; fluid in the cystic structures is usually uncontaminated, but if free in the uterus, it will support bacterial growth; progesterone also inhibits the local immune response and decreases myometrial contractility
Repeated pseudopregnancies may predispose some queens to CEH; progestins used to
control estrus also a risk factor
Diagnosis: queen is not ill but fails to conceive or has small litters; ultrasound may
detect thickening of uterus; definitive diagnosis only with uterine biopsy
No treatment for uncomplicated CEH; endometritis (CEH plus bacterial infection)
may respond to prolonged antibiotic treatment but can progress to pyometra
Pyometra Severe endometrial infection with accumulation of pus in uterus Typically occurs following an estrus, when bacteria from vagina invade uterus
through open cervix; usually associated with CEH
Vagina normally has bacteria present; vaginal cultures therefore hard to interpret;
most common bacteria are E. coli and Streptococcus, Staphylococcus, etc.
Clinical signs: Vulvar discharge (if cervix open), depression, dehydration, anorexia,
fever, weight loss, distended abdomen
Diagnosis: Increased white blood cell count, enlarged uterus on x-rays or ultrasound Treatment: IV fluids may be needed, antibiotics (fluoroquinolones, amoxicillin-
clavulanate) plus ovariohysterectomy (OHE) or prostaglandin therapy for valuable breeding queens
Antibiotics alone, vaginal douches not very effective Prostaglandin therapy: best for open-cervix; complication rate is low!
• Candidate queens are under 6 years, in good health (no asthma), no retained fetal
material or live fetuses, no complications (i.e. uterine torsion)
Prostaglandin F2α, dinoprost (Lutalyse , Pharmacia & Upjohn) treatment: queen
may or may not be hospitalized; different dosing options: High dose: 0.1 to 0.25 mg/kg SC twice daily for 5 to 7 days Low dose: 0.02 to 0.05 mg/kg SC 4-6 times daily for 5 to 10 days
• Treatment may cause cervix to open, uterus to contract, may cause lysis of CL
• Monitor for: rising fever, abdominal pain, systemic illness, uterine rupture
• Assess success of treatment by monitoring white blood cell counts, ultrasound • Side effects common at higher doses, especially first day: restlessness, vocalizing,
panting, vomiting, diarrhea, salivation, intense grooming of flanks and vulva; lasts 15-20 min; side effects uncommon at low doses (often only a bit of salivation)
• Re-examine cat 1 and 2 weeks post-treatment: clear vulvar discharge by day 7,
normal by 14 days; if bloody or purulent discharge persists, treat again
Bytown Cat Hospital 422 McArthur Ave. Ottawa, Ontario, Canada K1K 1G6
Phone 613-741-2460 [email protected] Fax 613-741-8463
• Breed at next heat! Fertility rates after treatment are good (80% or better)
• Adjunctive therapy:
Prolonged oral antibiotic therapy (4-6 weeks) Cabergoline (
Galastop , Boehringer Ingelheim): 5 µg/kg, PO, 5 days;
prolactin inhibitor, luteolytic, no side effects
Aglepristone (
Alizine , Virbac): progesterone receptor antagonist, 10-15
mg/kg, SC, 2 days in a row
References
Davidson, A.P. et al.: Treatment of pyometra in cats, using prostaglandin F2 alpha: 21
cases (1982-1990). J Amer Vet Med Assoc 200(6):825-828;1992.
Davidson, A.P.: Medical management of pyometra with prostaglandin F2 alpha in the
dog and cat. Kirk's Current Veterinary Therapy XII Small Animal Practice (J.D. Bonagura, ed.). W.B. Saunders, Philadelphia, P.A., 1995; pp 1081-1083.
Johnston, S.D. et al.: Clinical approach to the complaint of infertility in the queen.
Canine and Feline Theriogenology. W.B. Saunders, Philadelphia, P.A., 2001; pp 486-495.
Lawler, D.F. et al.: Histopathologic features, environmental factors, and serum estrogen,
progesterone, and prolactin values associated with ovarian phase and inflammatory uterine disease in cats. Amer J Vet Res 52(10):1747-1753; 1991.
Little, S. Uncovering the cause of infertility in queens. Vet Med 96(7): 557-568, 2001. Potter, K. et al.: Clinical and pathologic features of endometrial hyperplasia, pyometra,
and endometritis in cats: 79 cases (1980-1985). J Amer Vet Med Assoc 198(8):1427-1431; 1991.
Stabenfeldt, G.H.; Pedersen, N.C.: Reproduction and reproductive disorders. Feline
Husbandry: Diseases and Management in the Multiple Cat Environment (P.W. Pratt, ed.). American Veterinary Publications, Goleta, A.A., 1991; pp 129-162.
Wolf, A.M.: Infertility in the queen. Current Veterinary Therapy XI Small Animal
Practice (R.W. Kirk; J.D. Bonagura, eds.). W.B. Saunders, Philadelphia, P.A., 1992; pp 947-954.
Wright, P.J.; Watts, J.R.: The infertile female. Manual of Small Animal Reproduction and
Neonatology (G. Simpson; G. England; M. Harvey, eds.). British Small Animal Veterinary Association, Cheltenham, U.K., 1998; pp 17-33.
Bytown Cat Hospital 422 McArthur Ave. Ottawa, Ontario, Canada K1K 1G6
Phone 613-741-2460 [email protected] Fax 613-741-8463
DRUG FORMULARY for Feline Reproduction
10-15 mg/kg, SQ, 2 days
Alizine®
0.25 mg/cat, PO, 5 to 7 days
Parlodel®
Mammary hyperplasia,
5 µg/kg, PO, SID, 5 to 7 days
Galastop®
pyometra, abortion (after (combine with cloprostenol for
Dostinex®
Abortion (after 25 days,
5 µg/kg, SC, every 48 hours
Estrumate®
with cabergoline)
2 mg/cat, IM, SID first day, then
reduce dose to 1.0 or 0.5 mg SID for 4 more days (max. of 5 days)
GnRH (gonadorelin):
Induce ovulation when in 25 µg/cat, IM, once
Cystorelin®
Induce ovulation when in 250 µg/cat, IM, daily on first 3
Chorulon®
Postpone estrus (start in
2.5 mg/cat, PO, weekly;
Provera®,
2.0 mg/kg, IM, every 5 months
Depo-Provera® Megestrol acetate:
Postpone estrus (start in
2.5 mg/cat, PO, weekly
Ayerst Stimulate
milk 0.2-0.4 mg/kg, PO, TID
Reglan® and generics
Oxytocin Various
2.5-5.0 units/cat, IM every 20-30 minutes, max 3 doses
Postpone estrus (start in
100 mg/cat, SC, every 5 months
Delvosteron®
Prostaglandin F2α
Pyometra, induce
0.1-0.25 mg/kg, SQ, BID to TID
Lutalyse®
abortion after 35 days
Stop premature labor
0.03-0.08 mg/kg, BID to TID
Bricanyl®, Brethine®
Note: Many of these drugs are not licensed for use in the cat in all countries, or may not be
licensed for these indications. Not all medications are available in all countries or may not be
available in veterinary formulations. Drugs may be available under different brand names from
different manufacturers. Always consult your veterinarian about any medication for your cat.
Bytown Cat Hospital 422 McArthur Ave. Ottawa, Ontario, Canada K1K 1G6
Phone 613-741-2460 [email protected] Fax 613-741-8463
Source: http://www.rexringen.nu/jubileum/notes/Infertility_Queen_2006.pdf
Vrije Universiteit Brussel Regulation of beta2-Adrenergic Receptor Function by Conformationally SelectiveSingle-Domain IntrabodiesStaus, Dean P.; Wingler, Laura M.; Strachan, Ryan T.; Rasmussen, Soren G. F.; Pardon, Els;Ahn, Seungkirl; Steyaert, Jan; Kobilka, Brian K; Lefkowitz, Robert J. Published in:Molecular Pharmacology
Contents lists available at Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice:The role of serotonin and different forebrain neuronal subpopulations M. Häring , M. Grieb , K. Monory , B. Lutz F.A. Moreira a Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University Mainz, Duesbergweg 6, 55128 Mainz, Germanyb Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627, Belo Horizonte, MG 31270-901, Brazil